Skip to main content
Fig. 5 | BMC Gastroenterology

Fig. 5

From: Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study

Fig. 5

CT scans A diffuse lesions with 70% involvement unresected liver; B PD with > 1 line of systemic treatments; C 1st HAIC typical tumor stain illustrating vigorous lesions; D 2nd HAIC showed remarkable reduction in tumor stain; E PR achieved as per the mRECIST criteria with PFS > 6 months. CT, computer tomography; HAIC, hepatic arterial infusion chemotherapy; mRECIST, modified response evaluation criteria in solid tumors; PD, progressive disease; PFS, progression-free survival; PR, partial response

Back to article page